R. Kettler

3.2k total citations · 1 hit paper
60 papers, 2.5k citations indexed

About

R. Kettler is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, R. Kettler has authored 60 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 23 papers in Cellular and Molecular Neuroscience and 17 papers in Molecular Biology. Recurrent topics in R. Kettler's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Biochemical Acid Research Studies (5 papers). R. Kettler is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Biochemical Acid Research Studies (5 papers). R. Kettler collaborates with scholars based in Switzerland, Italy and Sweden. R. Kettler's co-authors include M. Da Prada, M. Da Prada, H. Thoenen, Josep Saura, J. G. Richards, P. U. Angeletti, Andrea M. Cesura, Rita Levi‐Montalcini, H. H. Keller and W. Haefely and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

R. Kettler

59 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective Induction by Nerve Growth Factor of Tyrosine Hydroxylase and Dopamine-β-Hydroxylase in the Rat Superior Cervical Ganglia

1971 258 citations H. Thoenen, P. U. Angeletti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Kettler Switzerland	25	1.1k	702	553	406	303	60	2.5k
R J Baldessarini United States	28	946 0.8×	746 1.1×	195 0.4×	229 0.6×	99 0.3×	62	2.1k
W.P. Burkard Switzerland	27	1.2k 1.1×	826 1.2×	265 0.5×	351 0.9×	90 0.3×	63	2.3k
Robert Zaczek United States	35	2.3k 2.0×	1.7k 2.5×	203 0.4×	352 0.9×	292 1.0×	91	3.8k
Boris Ferger Germany	35	1.7k 1.5×	1.1k 1.5×	1.2k 2.2×	364 0.9×	254 0.8×	100	3.8k
Saburo Otsuki Japan	29	1.7k 1.5×	1.1k 1.5×	269 0.5×	238 0.6×	168 0.6×	150	3.0k
Matthew P. Galloway United States	35	1.9k 1.7×	1.2k 1.7×	438 0.8×	330 0.8×	286 0.9×	86	3.5k
I.A. Paterson Canada	25	1.0k 0.9×	594 0.8×	391 0.7×	197 0.5×	109 0.4×	48	1.8k
Edilio Borroni Switzerland	35	1.9k 1.7×	1.5k 2.2×	882 1.6×	469 1.2×	229 0.8×	91	4.3k
W. Kehr Germany	29	2.5k 2.2×	1.3k 1.9×	333 0.6×	247 0.6×	82 0.3×	68	3.4k
Antonio Contestabile Italy	37	2.3k 2.0×	2.1k 3.0×	423 0.8×	560 1.4×	204 0.7×	146	5.1k

Countries citing papers authored by R. Kettler

Since Specialization

Citations

This map shows the geographic impact of R. Kettler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kettler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kettler more than expected).

Fields of papers citing papers by R. Kettler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kettler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kettler. The network helps show where R. Kettler may publish in the future.

Co-authorship network of co-authors of R. Kettler

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kettler. A scholar is included among the top collaborators of R. Kettler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kettler. R. Kettler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dingemanse, Jasper, G. Zürcher, & R. Kettler. (2000). Investigation of a correlation between monoamine oxidase B and catechol-O-methyltransferase activity in human blood cells. European Journal of Pharmaceutical Sciences. 12(2). 159–163. 3 indexed citations

Dingemanse, Jasper, Nolan Wood, Karin Jorga, & R. Kettler. (1997). Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO‐6 inhibitor lazabemide in healthy subjects. British Journal of Clinical Pharmacology. 43(1). 41–47. 9 indexed citations

Röver, Stephan, et al.. (1997). Synthesis and Biochemical Evaluation ofN-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase. Journal of Medicinal Chemistry. 40(26). 4378–4385. 179 indexed citations

Bös, Michael, et al.. (1995). Resolution, EPC‐Syntheses, Absolute Stereochemistry, and Pharmacology of the (S)‐(+)‐ and (R)‐(—)‐Isomers of the MAO‐A Inhibitor Tetrindole Hydrochloride. Archiv der Pharmazie. 328(7-8). 619–622. 2 indexed citations

Luque, Juan M., et al.. (1994). Radioautographic Evidence that the GABA_A Receptor Antagonist SR 95531 is a Substrate Inhibitor of MAO‐A in the Rat and Human Locus Coeruleus. European Journal of Neuroscience. 6(6). 1038–1049. 15 indexed citations

Kuhn, C, et al.. (1994). Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings. PubMed. 41. 321–325. 20 indexed citations

Haefely, W., W.P. Burkard, Andrea M. Cesura, et al.. (1992). Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology. 106(S1). S6–S14. 85 indexed citations

Burkard, W.P., Francesco D’Agostini, R. Kettler, & M. Da Prada. (1992). Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats. Psychopharmacology. 106(S1). S35–S36. 3 indexed citations

Saura, Josep, R. Kettler, M. Da Prada, & J. G. Richards. (1992). Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19- 6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. Journal of Neuroscience. 12(5). 1977–1999. 284 indexed citations

10.

Zürcher, G., et al.. (1990). Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats.. PubMed. 53. 497–503. 76 indexed citations

11.

Price, Gary, S. K. Luthra, David R. Turton, et al.. (1990). Inhibition of brain monoamine oxidase-B by Ro19-6327 — in vivo measurerment using positron emission tomography. European Journal of Pharmacology. 183(2). 166–166. 4 indexed citations

12.

Kettler, R., M. Da Prada, & W.P. Burkard. (1990). Comparison of monoamine oxidase‐A inhibition by moclobemide in vitro and ex vivo in rats. Acta Psychiatrica Scandinavica. 82(S360). 101–102. 37 indexed citations

13.

Colzi, A., Francesco D’Agostini, R. Kettler, Edilio Borroni, & M. Da Prada. (1990). Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study. PubMed. 32. 79–84. 33 indexed citations

14.

Prada, M. Da, R. Kettler, H. H. Keller, & W.P. Burkard. (1990). Short‐lasting and reversible inhibition of monoamine oxidase‐A by moclobemide. Acta Psychiatrica Scandinavica. 82(S360). 103–105. 11 indexed citations

15.

Prada, M. Da, H. H. Keller, & R. Kettler. (1989). [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].. PubMed. 16 Suppl 1. 18–24. 5 indexed citations

16.

Cesura, Andrea M., R. Imhof, M. D. Galva, R. Kettler, & M. Da Prada. (1988). Interactions of the novel inhibitors of MAO B Ro 19-6327 and Ro 16-6491 with the active site of the enzyme. Pharmacological Research Communications. 20. 51–61. 13 indexed citations

17.

Wiesel, F.‐A., J Raaflaub, & R. Kettler. (1985). Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites. European Journal of Clinical Pharmacology. 28(1). 89–95. 17 indexed citations

18.

Kettler, R., et al.. (1984). Minimal potentiation of pressor response to oral tyramine in rats given moclobemide alone or combined with sodium uptake inhibitors. 36. 41. 1 indexed citations

19.

Haeusler, G., H.P. Lorez, G. Bartholini, R. Kettler, & J. P. Tranzer. (1974). ABSENCE OF DEGENERATION OF ADRENERGIC NEURONS AFTER PROLONGED TREATMENT WITH DEBRISOQUIN. Journal of Pharmacology and Experimental Therapeutics. 189(3). 646–658. 7 indexed citations

20.

Angeletti, P. U., Rita Levi‐Montalcini, R. Kettler, & H. Thoenen. (1972). Comparative studies on the effect of the nerve growth factor on sympathetic ganglia and adrenal medulla in newborn rats. Brain Research. 44(1). 197–206. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact